DMA Destra Multi-Alternative Fund Insider Trading

10% owner Saba Capital buys 68,449 DMA shares at $8.60; second buy in 4 days.

Saba Capital Management, L.P., a 10% owner of Destra Multi-Alternative Fund, purchased 68,449 shares at $8.60 on 2025-09-09, the second open-market buy in as many days (prior buy on 2025-09-08). This incremental accumulation lifted holdings from 2,166,695 to 2,235,144 shares, a +3.2% increase. The current price of $8.80 sits 3.3% below the 52-week high of $9.10, placing this trade neither at a notable valuation extreme nor at a 52-week low. Across Saba's cross-ticker track record, 11 prior buys and 9 prior sells show balanced activity without a demonstrable edge in timing outcomes. The consecutive-day purchasing pattern and modest accumulation size provide limited basis for inferring directional conviction at this juncture.

Saba Capital bought 500 DMA shares at $8.58 on 2025-09-08; 2.17M shares held post-transaction.

Saba Capital Management, a 10% owner, purchased 500 shares of Destra Multi-Alternative Fund (DMA) at $8.58, a price 0.8% below the current $8.65 level and 5.7% below the 52-week high of $9.10. The transaction increased holdings from 2.17M shares to 2.17M shares, representing a net addition of 500 shares (+0.0% change). The cross-ticker track record shows 10 prior buys and 10 prior sells with no measurable timing advantage at the 90-day mark. Prior trades at DMA (2 buys on 2025-09-09 and 2025-09-05) do not yet have measurable 30-day or 90-day outcomes. The modest share acquisition and immaterial percentage change to holdings suggest routine incremental activity rather than a material conviction signal.

Saba Capital Management (10% owner) buys 27,923 shares of DMA at $8.57 (239.3K), raising stake to 2.17M shares post-transaction.

Saba Capital Management, a 10% shareholder, purchased 27,923 shares at $8.57 on 2025-09-05, increasing holdings to 2.17M shares (+1.3% from 2.14M pre-transaction). The purchase occurred near mid-range of the 52-week band ($7.35–$9.10), with the stock currently at $8.61 (slightly below transaction price). Cross-ticker, this insider maintains an even record of 10 prior buys and 10 prior sells, offering no directional pattern. At DMA specifically, one subsequent transaction occurred (buy on 2025-09-08), with outcomes not yet measurable. The transaction represents a modest incremental stake increase; investor attention should track whether this signals material repositioning or routine portfolio management by the 10% holder.

10% owner Saba Capital buys 41,802 DMA shares at $8.66; holdings reach 2.14M (+2.0%)

Saba Capital Management purchased 41,802 shares of DMA at $8.66 on 2025-08-14, expanding its 2.14M-share position by 2.0%. This is the firm's third accumulation at DMA in two weeks (following buys on 2025-07-28 and 2025-07-29), suggesting continued interest in the fund despite recent price weakness: DMA trades at $8.63 currently, -5.2% from its 52-week high and -4.5% over 90 days. Saba's cross-ticker track record shows 12 prior open-market buys with an average 30-day return of -1.5%, and its prior same-ticker outcomes at DMA remain unmeasurable, limiting inference about the accuracy of this buying pattern. The repetition of purchases within a narrow timeframe at a 10%+ ownership stake is the primary indicator of continued conviction, though price action has been mixed.

Saba Capital, 10% owner of DMA, acquires 138,416 shares in 2 transactions for $1,185,503.22 at $8.52–$8.62

Saba Capital completed 2 separate purchases totaling 138,416 shares for $1,185,503.22 on consecutive trading days (July 28–29, 2025) at prices of $8.52 and $8.62, executing a blended average of $8.56. This acquisition increased the firm's holdings by 7.1% from 1,958,054 to 2,096,470 shares. At the current price of $8.68, the stock trades only 0.1% above the blended transaction price, suggesting the purchases were recently executed near current market levels. Saba's cross-ticker track record shows 16 prior buys with an average 30-day return of +0.7%, providing modest context for buy-side activity patterns, though same-ticker historical outcomes for DMA are not disclosed in this filing.

Saba Capital Management bought 3,300 DMA shares at $8.63 on 2025-05-15, bringing holdings to 1,958,054 shares.

Saba Capital Management, a 10% owner, purchased 3,300 shares of Destra Multi-Alternative Fund at $8.63 on 2025-05-15, expanding post-transaction holdings to 1,958,054 shares. The purchase represents a modest +0.2% net change in holdings. This buy follows another purchase at the same ticker on 2025-05-13, showing consecutive accumulation activity over a two-day period, though neither transaction is yet measurable on a 90-day basis. The current price of $8.89 stands near the 52-week high of $9.10 and reflects recent positive momentum (30-day change: +10.7%), placing the transaction within a broader uptrend for the fund.

10% owner Saba Capital bought 19,595 DMA shares at $8.53; four DMA purchases in 5 days, holdings now 1,954,754 shares.

Saba Capital Management executed a $167,145.35 purchase of 19,595 shares at $8.53 on 2025-05-13, increasing holdings to 1,954,754 shares (+1.0% net change). This transaction is part of a concentrated activity pattern: the insider made four separate purchases at DMA between 2025-05-08 and 2025-05-15, signaling sustained accumulation within a tight five-day window. The current price of $8.64 is 1.3% above the 2025-05-13 transaction price and shows +8.7% appreciation over the 30-day period, placing the stock near its 52-week high of $9.10. Across the insider's broader cross-ticker trading history (14 prior buys, 6 prior sells), no measurable timing pattern has emerged; however, the rapid-fire succession of four purchases at this specific ticker within days suggests focused positioning rather than incidental activity.

Saba Capital Management acquired 42,913 shares of DMA at $8.51 on 2025-05-12, expanding stake to 1,935,159 shares.

Saba Capital Management, a 10% owner, purchased 42,913 shares at $8.51 for $365,189.63, increasing holdings by 2.3% to 1,935,159 shares post-transaction. The purchase comes as DMA trades near its 52-week midpoint (currently $8.61, up 9.0% over 30 days but down 5.4% from the 52-week high of $9.10). Notably, this represents the third consecutive purchase at DMA in four trading days (purchases on 2025-05-08, 2025-05-09, and 2025-05-12), suggesting sustained accumulation activity. However, the near-term timing cannot yet be assessed, as the 30-day and 90-day outcomes for these recent trades are not yet measurable.

Saba Capital Management (10% owner) acquired 39,683 shares at blended avg $8.43 across 2 purchases on 2025-05-08/09.

Saba Capital Management purchased 39,683 shares over two consecutive trading days (May 8–9, 2025) at an average price of $8.43, increasing its position in Destra Multi-Alternative Fund from 1.85M to 1.89M shares (+2.1%). The transactions totaled $334,535.39. At the current price of $8.48, the trades are marginally above cost basis, though the stock remains 6.8% below its 52-week high of $9.10 and has moved +7.3% over the prior 30 days. The timing context is limited: Saba's prior trades at DMA are not yet measurable at the 90-day mark, and across its cross-ticker open-market history, 13 prior buys versus 7 prior sells provides modest positioning data but no clear pattern of timing accuracy.

Saba Capital Management bought 976 shares of DMA at $8.32 on 2025-05-05, bringing holdings to 1,852,563 shares.

Saba Capital Management, a 10% owner, purchased 976 shares of Destra Multi-Alternative Fund (DMA) at $8.32 on 2025-05-05 for a total value of $8,120.32, representing a minimal net increase of +0.1% to its existing position of 1,851,587 shares. This buy occurred immediately after two prior purchases at the same ticker on 2025-05-02 and 2025-05-01, suggesting consistent acquisition activity over a three-day window. The current price of $8.34 stands -8.4% from the 52-week high of $9.10, though it has appreciated +6.9% over the prior 30 days. The trade's modest size relative to the insider's total holdings and the absence of measurable 90-day outcomes on the two preceding same-ticker trades limit the inference of meaningful strategic positioning at this stage.